<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>In vitro/in vivo study &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/in-vitro-in-vivo-study/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 13:38:45 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>In vitro/in vivo study &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Dronedarone Suppresses Esophageal Squamous Cell Carcinoma Growth via CDK4/CDK6-RB1 Pathway: In Vitro and In Vivo Insights</title>
		<link>https://bioengineer.org/dronedarone-suppresses-esophageal-squamous-cell-carcinoma-growth-via-cdk4-cdk6-rb1-pathway-in-vitro-and-in-vivo-insights/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 07 Jan 2025 03:15:21 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[CDK4/CDK6-RB1 pathway]]></category>
		<category><![CDATA[Dronedarone]]></category>
		<category><![CDATA[Drug repurposing]]></category>
		<category><![CDATA[Esophageal squamous cell carcinoma]]></category>
		<category><![CDATA[In vitro/in vivo study]]></category>
		<guid isPermaLink="false">https://bioengineer.org/dronedarone-suppresses-esophageal-squamous-cell-carcinoma-growth-via-cdk4-cdk6-rb1-pathway-in-vitro-and-in-vivo-insights/</guid>

					<description><![CDATA[Esophageal squamous cell carcinoma (ESCC) emerges as a significant health concern worldwide, characterized by its aggressive nature and poor prognosis despite available treatment options. The pressing need for innovative therapeutic strategies drives ongoing research into potential treatments for this prevalent cancer type. In recent studies, researchers have turned their attention to repurposing existing medications, with [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">233185</post-id>	</item>
	</channel>
</rss>
